Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (291-300 of 504) with videos related to

Pageof 51
Sort By:
Blood|July 25, 2012
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironmentZhihong Zeng, Yue Xi Shi, Twee Tsao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar, et al.
The Journal of Clinical Investigation|May 16, 2012
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesisVenkata Lokesh Battula, Yuexi Shi, Kurt W Evans, et al.
Frontiers in Oncology|July 23, 2020
Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse ModelMateusz Rytelewski, Karine Harutyunyan, Natalia Baran, et al.
Plos One|August 29, 2015
Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian CancersYan Zhang, Aleksandra Nowicka, Travis N Solley, et al.
Blood Advances|September 23, 2021
Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti-PD-1-based therapyHussein A Abbas, Zoe Alaniz, Sean Mackay, et al.
Blood|October 29, 2008
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AMLZhihong Zeng, Yue Xi Shi, Ismael J Samudio, et al.
Blood|September 28, 2002
The triterpenoid CDDO induces apoptosis in refractory CLL B cellsIrene M Pedersen, Shinichi Kitada, Aaron Schimmer, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 5, 2012
A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemiaKhanh Vu, Naifa Busaidy, Maria E Cabanillas, et al.
Blood|November 2, 2006
MEK blockade converts AML differentiating response to retinoids into extensive apoptosisMichele Milella, Marina Konopleva, Cristina M Precupanu, et al.
Pageof 51

Showing results (291-300 of 504) with videos related to

Sort By:
Pageof 51
Blood|July 25, 2012
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironmentZhihong Zeng, Yue Xi Shi, Twee Tsao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar, et al.
The Journal of Clinical Investigation|May 16, 2012
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesisVenkata Lokesh Battula, Yuexi Shi, Kurt W Evans, et al.
Frontiers in Oncology|July 23, 2020
Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse ModelMateusz Rytelewski, Karine Harutyunyan, Natalia Baran, et al.
Plos One|August 29, 2015
Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian CancersYan Zhang, Aleksandra Nowicka, Travis N Solley, et al.
Blood Advances|September 23, 2021
Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti-PD-1-based therapyHussein A Abbas, Zoe Alaniz, Sean Mackay, et al.
Blood|October 29, 2008
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AMLZhihong Zeng, Yue Xi Shi, Ismael J Samudio, et al.
Blood|September 28, 2002
The triterpenoid CDDO induces apoptosis in refractory CLL B cellsIrene M Pedersen, Shinichi Kitada, Aaron Schimmer, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 5, 2012
A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemiaKhanh Vu, Naifa Busaidy, Maria E Cabanillas, et al.
Blood|November 2, 2006
MEK blockade converts AML differentiating response to retinoids into extensive apoptosisMichele Milella, Marina Konopleva, Cristina M Precupanu, et al.
Pageof 51